Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

322 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of fibrinolysis on bleeding phenotype in moderate and severe von Willebrand disease.
De Wee EM, Klaij K, Eikenboom HC, Van Der Bom JG, Fijnvandraat K, Laros-Van Gorkom BA, Mauser-Bunschoten EP, Meijer K, Goverde G, Van Der Linden PW, Rijken DC, Leebeek FW; WiN Study Group. De Wee EM, et al. Among authors: van der linden pw, van der bom jg. Haemophilia. 2012 May;18(3):444-51. doi: 10.1111/j.1365-2516.2011.02645.x. Epub 2011 Sep 12. Haemophilia. 2012. PMID: 21910790
Large deletions and small insertions and deletions in the factor VIII gene predict unfavorable immune tolerance induction outcome in people with severe hemophilia A and high-responding inhibitors.
Zuccherato LW, Souza RP, Camelo RM, Dias MM, Jardim LL, Santana MAP, Oliveira AG, Lorenzato CS, Cerqueira MH, Franco VKB, Ribeiro RA, Etto LY, Roberti MDRF, Callado FMA, de Cerqueira MAF, Pinto ISS, Garcia AA, Anegawa TH, Neves DCF, Tan DM, Tou RP, Chaves DG, van der Bom J, Rezende SM; HEMFIL Study and the Brazilian Immune Tolerance (BrazIT) Study. Zuccherato LW, et al. Thromb Res. 2024 Oct;242:109115. doi: 10.1016/j.thromres.2024.109115. Epub 2024 Aug 14. Thromb Res. 2024. PMID: 39186847
Variations in antenatal management and outcomes in haemolytic disease of the fetus and newborn: an international, retrospective, observational cohort study.
de Winter DP, Lopriore E, Thorup E, Petersen OB, Dziegiel MH, Sundberg K, Devlieger R, de Catte L, Lewi L, Debeer A, Houfflin-Debarge V, Ghesquiere L, Garabedian C, Le Duc K, Antolin E, Mendez N, Castleman J, Tse WT, Jouannic JM, Maurice P, Currie J, Mullen E, Geerts L, Rademan K, Khalil A, Poljak B, Prasad S, Tiblad E, Bohlin K, Geipel A, Rath J, Malone F, Mackin D, Yinon Y, Cohen S, Ryan G, Vlachodimitropoulou E, Gloning KP, Verlohren S, Mayer B, Lanna M, Faiola S, Sršen TP, Cerar LK, Snowise S, Sun L, Otaño L, Meller CH, Connors NK, Saxonhouse M, Wolter A, Bedei I, Klaritsch P, Jauch S, da Silva Ribeiro ET, Filho FMP, Martinez-Portilla RJ, Matias A, Abad OA, Roca JP, Grisi ÁGA, Navarro EJJC, van der Bom JG, de Haas M, Verweij EJ; DIONYSUS investigators. de Winter DP, et al. Among authors: van der bom jg. Lancet Haematol. 2024 Nov 8:S2352-3026(24)00314-4. doi: 10.1016/S2352-3026(24)00314-4. Online ahead of print. Lancet Haematol. 2024. PMID: 39527958
Response to Letter.
Bonsen LR, van der Bom JG. Bonsen LR, et al. Among authors: van der bom jg. Obstet Gynecol. 2024 Nov 1;144(5):e108-e109. doi: 10.1097/AOG.0000000000005739. Obstet Gynecol. 2024. PMID: 39418660 No abstract available.
Patient-reported data on the severity of Von Willebrand disease.
van Kwawegen CB, Fijnvandraat K, Kruip MJHA, de Meris J, Schols SEM, Meijer K, van der Bom JG, Cnossen MH, van Galen KPM, Atiq F, Eikenboom J, Leebeek FWG; WiN study group. van Kwawegen CB, et al. Among authors: van der bom jg. Haemophilia. 2024 Oct 15. doi: 10.1111/hae.15103. Online ahead of print. Haemophilia. 2024. PMID: 39403864
Genetic variants, thrombocytopenia, and clinical phenotype of type 2B von Willebrand disease: a median 16-year follow-up study.
van Kwawegen CB, Atiq F, Endenburg D, Fijnvandraat K, van Galen KPM, Cnossen MH, Schols SEM, Kruip MJHA, van Heerde WL, de Meris J, van der Bom JG, Eikenboom J, Meijer K, Leebeek FWG; WiN study group. van Kwawegen CB, et al. Among authors: van der bom jg. J Thromb Haemost. 2024 Sep 28:S1538-7836(24)00555-5. doi: 10.1016/j.jtha.2024.08.028. Online ahead of print. J Thromb Haemost. 2024. PMID: 39343102 Free article.
Additional Strategies to Minimize Blood Loss in Babies Born Very Preterm.
Heeger LE, Koster MI, Caram-Deelder CC, Bekker V, van der Bom JG, Lopriore E. Heeger LE, et al. Among authors: van der bom jg. J Pediatr. 2024 Oct;273:114198. doi: 10.1016/j.jpeds.2024.114198. Epub 2024 Jul 15. J Pediatr. 2024. PMID: 39019319 No abstract available.
Most major bleeds in preterm infants occur in the absence of severe thrombocytopenia: an observational cohort study.
van der Staaij H, Hooiveld NMA, Caram-Deelder C, Fustolo-Gunnink SF, Fijnvandraat K, Steggerda SJ, de Vries LS, van der Bom JG, Lopriore E. van der Staaij H, et al. Among authors: van der bom jg. Arch Dis Child Fetal Neonatal Ed. 2024 Jul 15:fetalneonatal-2024-326959. doi: 10.1136/archdischild-2024-326959. Online ahead of print. Arch Dis Child Fetal Neonatal Ed. 2024. PMID: 39009429
322 results